DDIT4 is an attractive potential target for therapeutic approach in cancer12 silencing of which leads to sensitization of tumor cells to cancer treatment and drugs in in-vitro and in-vivo studies19,22,30,33. This evidence concerns the gene DDIT4 and neoplasm.